•  98
    Correction to: Synthetic Biology and the Translational Imperative
    with Raheleh Heidari Feidt, Bernice Simone Elger, and Marc Folcher
    Science and Engineering Ethics 25 (1): 53-53. 2019.
    The author group of above-mentioned review paper was incorrectly published in the online article.
  •  119
    Synthetic Biology and the Translational Imperative
    with Raheleh Heidari Feidt, Bernice Simone Elger, and Marc Folcher
    Science and Engineering Ethics 25 (1): 33-52. 2019.
    Advances at the interface between the biological sciences and engineering are giving rise to emerging research fields such as synthetic biology. Harnessing the potential of synthetic biology requires timely and adequate translation into clinical practice. However, the translational research enterprise is currently facing fundamental obstacles that slow down the transition of scientific discoveries from the laboratory to the patient bedside. These obstacles including scarce financial resources an…Read more
  •  321
    Brain–computer interfacing technologies are used as assistive technologies for patients as well as healthy subjects to control devices solely by brain activity. Yet the risks associated with the misuse of these technologies remain largely unexplored. Recent findings have shown that BCIs are potentially vulnerable to cybercriminality. This opens the prospect of “neurocrime”: extending the range of computer-crime to neural devices. This paper explores a type of neurocrime that we call brain-hackin…Read more